Oct 24 2011 | News
Momenta Pharmaceuticals Inc. said Monday that its partner Sandoz's launch of a generic version of the blood thinner Lovenox will trigger royalty payments when Sandoz starts selling the drug during the fourth quarter.
|
Oct 28 2010 | News
Sandoz Inc.has initiated a voluntary recall in the US of all
50mg/2mL and 250mg/10mL vials of Sandoz and Parenta brand Methotrexate
Injection, USP product ("methotrexate") to the consumer/user level.
|
Aug 26 2010 | News
Momenta Pharmaceuticals today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox(R).
|
Nov 10 2009 | News
NEW YORK (AP) — Teva Pharmaceutical Industries Ltd. said Tuesday it plans to expand a suit against Momenta Pharmaceuticals Inc. and Sandoz Inc., which are hoping to market a generic version of Teva's multiple sclerosis drug Copaxone.
|
Oct 14 2009 | News
NEW YORK (AP) — Irish drugmaker Shire PLC said Tuesday it settled patent lawsuits against Novartis AG's Sandoz unit, which was trying to market a generic version of Shire's attention deficit hyperactivity disorder drug Adderall XR.
|
Oct 8 2009 | News
BRUSSELS (AP) — Sanofi-Aventis SA, Novartis AG and Ratiopharm International GmbH said Wednesday that EU regulators had carried out surprise raids at their French offices as part of an antitrust probe.
|
Sep 15 2009 | News
AMRI has filed two new patent infringement lawsuits in U.S. District Court in New Jersey against Dr. Reddy’s Laboratories, Ltd., Dr. Reddy’s Laboratories, Inc. and Sandoz, Inc. (“the defendants”) for infringement of AMRI’s U.S. Patent Number 7,390,906.
|
Aug 13 2009 | News
NEW YORK (AP) — Novartis AG's Sandoz unit has launched a generic version of the drug Prograf, which is used to help prevent rejection of a transplanted kidney or liver. The drug, also called tracrolimus, suppresses the immune system to keep it from attacking the transplanted organ.
|
Jul 28 2009 | News
NEW YORK (AP) — Shares of Medicis Pharmaceutical Corp. advanced Tuesday after the company said regulators approved two new doses of its top drug, the acne treatment Solodyn. Medicis said the Food and Drug Administration approved 65 mg and 115 mg doses of acne drug Solodyn.
|
Jun 25 2009 | News
FRANKFORT, Ky. (AP) — Kentucky Attorney General Jack Conway says a Franklin County jury has handed down a $16 million judgment against Sandoz, the generic-drugs division of pharmaceutical giant Novartis.
|